Sun Pharma

Showing of 1 - 20 from 349 results
Sun Pharma - Total results - 349
Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill
science

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill

Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.

Shares hold on gains for fifth straight session; Kotak Mahindra Bank shares offset impact of Moody's ratings cut
Business

Shares hold on gains for fifth straight session; Kotak Mahindra Bank shares offset impact of Moody's ratings cut

Kotak Mahindra Bank was the top gainer in the Sensex pack, rising around 7 percent, followed by M&M, Sun Pharma, Hero MotoCorp, Bajaj Finance, Tata Steel, Bharti Airtel and HCL Tech.

Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Business

Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Sensex rebounds 224 points from day's low, Nifty at 9,580; ONGC top gainer, jumps over 5%
Business

Sensex rebounds 224 points from day's low, Nifty at 9,580; ONGC top gainer, jumps over 5%

Sensex jumped 224 points on Friday, driven by gains in HDFC, ITC and HUL despite weak cues from global markets.

Markets open weak: Sensex drops over 300 points, Nifty tests 9,400-level in early trade ahead of GDP data; Rupee up
Business

Markets open weak: Sensex drops over 300 points, Nifty tests 9,400-level in early trade ahead of GDP data; Rupee up

Sensex tumbled over 300 points in early trade on Friday dragged by losses in HDFC Bank, Infosys, TCS and Reliance Industries amid weak cues from global markets.

Sun Pharma, SPARC ink pact for potential treatment for atopic dermatitis, auto-immune disorders
Business

Sun Pharma, SPARC ink pact for potential treatment for atopic dermatitis, auto-immune disorders

Sun Pharmaceutical Industries Ltd and Sun Pharma Advanced Research Company (SPARC) on Thursday said they have entered into a worldwide licensing pact for development and commercialisation of a novel molecule which can be used for the potential treatment of atopic dermatitis, psoriasis and other auto-immune disorders

Markets end strong after subdued sessions: Sensex rallies over 990 points, Nifty surges to 9,315; Axis Bank top gainer, soars over 13%
Business

Markets end strong after subdued sessions: Sensex rallies over 990 points, Nifty surges to 9,315; Axis Bank top gainer, soars over 13%

Sensex rallied 996 points on Wednesday, led by massive gains in banking and IT stocks ahead of the expiry of monthly derivatives amid firm overseas cues.

Indices fall tracking decline in Asian markets; Sensex, Nifty slide as fiscal stimulus spend relatively small
Business

Indices fall tracking decline in Asian markets; Sensex, Nifty slide as fiscal stimulus spend relatively small

Sensex slumped over 600 points in opening session on Thursday dragged by losses in index heavyweights Infosys, HDFC twins, Reliance Industries and ICICI Bank amid weak cues from global markets.

Market ends on positive note; Sensex jumps 637 points, Nifty above 9,350; Re settles higher at Rs 75.46 against dollar
Business

Market ends on positive note; Sensex jumps 637 points, Nifty above 9,350; Re settles higher at Rs 75.46 against dollar

The Nifty bank index was up by 4 percent. Besides, sharp buying was also witnessed in the auto and metal stocks.

Markets open weak: Sensex slumps over 400 points, Nifty drops below 9,200-mark; bank stocks slide
Business

Markets open weak: Sensex slumps over 400 points, Nifty drops below 9,200-mark; bank stocks slide

Sensex dropped over 400 points in opening session on Tuesday dragged by losses in index-heavyweights HDFC twins, Reliance Industries and ICICI Bank amid weak cues from global markets.

Markets close on positive note: Sensex 199 points up, propelled by strong gains in RIL; rupee closes higher
Business

Markets close on positive note: Sensex 199 points up, propelled by strong gains in RIL; rupee closes higher

Reliance Industries was the biggest contributor to the gains on the index, jumping over 3 percent after the company announced that US-based PE firm Vista Equity Partners will buy 2.32 percent stake in Jio Platforms for Rs 11,367 crore.

Markets end in red: Sensex plummets 2,002 points, Nifty suffers heavy loss of over 560 points; ICICI Bank top loser
Business

Markets end in red: Sensex plummets 2,002 points, Nifty suffers heavy loss of over 560 points; ICICI Bank top loser

Sensex plunged 5.94 percent or 2,002 points on Monday, tracking massive selloffs in global markets amid rising US-China tensions.

Sensex jumps over 400 points tracking gains in financial stocks, Nifty above 9,340-level; IndusInd Bank top gainer
Business

Sensex jumps over 400 points tracking gains in financial stocks, Nifty above 9,340-level; IndusInd Bank top gainer

Shares of Indusind Bank surged 10 percent following the private-sector lender’s quarterly results after the bell on Monday.

Stock markets open in green: Sensex rallies over 600 points, Nifty tops 9,300-mark in early trade; Rupee up
Business

Stock markets open in green: Sensex rallies over 600 points, Nifty tops 9,300-mark in early trade; Rupee up

The Nifty advanced 1.7 percent to 9,310.15 while the benchmark Sensex gained 1.74 percent at 31,850.43.

Sensex, Nifty trade in green in opening session: RIL stocks zoom, rallies over 7% after Facebook announces investment
Business

Sensex, Nifty trade in green in opening session: RIL stocks zoom, rallies over 7% after Facebook announces investment

Sensex rose over 200 points in opening trade lifted by strong gains in index heavyweight Reliance Industries even as weak cues from global markets weighed on overall market sentiment.

Market closes flat: Sensex, Nifty marginally up on tepid cues from global markets; HDFC, RIL, IT stocks close with gains
Business

Market closes flat: Sensex, Nifty marginally up on tepid cues from global markets; HDFC, RIL, IT stocks close with gains

Sensex ended 59 points higher after a highly volatile session on Monday amid tepid cues from global markets as concerns over COVID-19 kept investors on edge.

Market soars post-RBI boost: Sensex jumps 986 points, Nifty zooms to 9,266-level; banking, energy, IT stocks major gainers
Business

Market soars post-RBI boost: Sensex jumps 986 points, Nifty zooms to 9,266-level; banking, energy, IT stocks major gainers

Given the strong monetary measures by the RBI and peaking coronavirus cases in the US, risky sectors could gain next week given attractive valuation.

Markets close on positive note: Sensex rises over 222 points buoyed by gains in finance, energy, power stocks; Nifty settles near 9,000-mark
Business

Markets close on positive note: Sensex rises over 222 points buoyed by gains in finance, energy, power stocks; Nifty settles near 9,000-mark

NTPC was the top gainer in the Sensex pack, rallying nearly 6 percent, followed by ICICI Bank, Titan, L&T, SBI, Sun Pharma and Nestle India